Cypris raises $4M to help R&D teams track global innovation

January 19, 2023
# min read

NEW YORK, NY, January 19th, 2023 - Cypris, a research platform for R&D teams, today announced a $4M Series A, led by York IE with notable institutional co-investors, Activate VP, K20 Fund & BlueTree Capital. The investment will enable Cypris to further its mission of helping R&D teams track and analyze global innovation through a single comprehensive platform.

Launched in 2021, the Cypris platform allows users to gain unique insights on technologies and companies from 500M+ live data points from sources like global patents, research papers, market news, and more. Cypris is empowering engineers much like Alphasense does for finance and PitchBook does for venture capital. 

Today, R&D teams rely on misaligned or archaic software and costly service providers to answer pressing questions that can hold a significant impact on their long term product roadmap. Engineering teams are also increasingly tasked with building business cases around the verticals they’re looking to invest in, without being armed with the proper data—a daunting and time consuming task. Cypris releases that time consuming hold, while enabling new innovation discovery, by centralizing multiple disparate datasets in one single location. 

“There are more platform innovations being introduced to markets today than at any point in history, across a wide spectrum of verticals,” said Steve Hafif, founder and CEO, Cypris. “Innovations in AI, blockchain, genomics, GPT, all have the power to drastically alter the evolution of even the most specialized markets. The responsibility of tracking these potentially disruptive technological breakthroughs, in many cases, are falling to R&D leaders. Without the proper tools they’re flying blind.”

Through the platform, users can run queries on virtually any keyword, competitor name or forward-looking concept and receive an automated and interactive report built on the historical and current status of innovation on the field or company. The data is pulled from a large proprietary database that the Cypris team curates and updates daily, which consists of major datasets like research papers, patents, product launch news, and more.

Searches that users perform can be saved into reports and grouped into projects that allow for sharing, collaboration among team members, and monitoring of key events within that space like lawsuits, new product launches, unusual market activity, IPOs, and more. Cypris also ensures competitive behavior and pivotal market movements don’t go unnoticed, to allow R&D teams to build their product roadmaps based on relevant and timely data. 

“We’ve found that Cypris is becoming a core part of an R&D team’s basic research process. Users are spending time at the earliest level of a project to build reports surrounding keywords and competitors within a landscape, then adding robust monitoring links to have updates come to them. This gives teams the chance to develop with confidence, and spend less time on dashboards and more time in the lab,” said Steve. 

Although Cypris currently markets to R&D as it’s core user profile, the platform has also proven to be beneficial for professionals in M&A, business development, finance, and venture capital, as an effective tool for conducting advanced technical inquiries.

"Over the past year, Cypris has generated strong product market fit with large enterprise customers across multiple verticals," said Joe Rackza, co-founder and managing partner, York IE. "This success shows that Cypris is becoming a mission critical tool for R&D and innovation teams. While we believe strongly in the market opportunity, we also know Steve is building the right team to capitalize on it. He has a great grasp on their market, business fundamentals, and how to grow the company." 

Cypris plans to use the new funding to invest deeper into their AI applications to decrease ‘time to insights’ for users and to create new opportunities for innovation discovery through the platform. 

For more information on Cypris, visit their website.

About Cypris:

Cypris is a market intelligence platform built for research and development and innovation teams. Designed to serve as a single ecosystem for global innovation data, the Cypris platform allows users to gain unique insights from 500M+ global data points to answer key questions about their market, competitors, core technologies, and more to support new product development, commercial strategy, and accelerate global innovation. To learn more about Cypris and how they help R&D and innovation teams, visit their website.

Press Contact:

McKenna Cosway

mckennac@cypris.ai

Similar insights you might enjoy

Best Prior Art Search Software for 2026: AI Tools and Enterprise Platforms Compared

Prior art search software in 2026 ranges from legacy patent platforms to free tools to modern enterprise R&D intelligence systems. Cypris represents the current state of the art for enterprise teams, combining a proprietary R&D ontology with unified access to 500+ million patents and scientific publications and AI-powered synthesis trusted by Fortune 100 companies including Johnson & Johnson, Honda, and Yamaha. Legacy platforms like Orbit Intelligence and Derwent Innovation continue serving patent professionals who value traditional Boolean search precision and established workflows, though their patent-centric architectures and older interfaces limit applicability for broader technology research. Free tools including Google Patents, Espacenet, USPTO Patent Public Search, and PQAI provide accessible starting points for preliminary research but lack the data coverage, AI sophistication, and enterprise capabilities required for comprehensive prior art analysis. Organizations should evaluate platforms based on data breadth across patents and non-patent literature, AI architecture and whether platforms employ domain-specific ontologies, integration with R&D workflows, and alignment with whether users are patent professionals or corporate research teams.

Best Prior Art Search Software for 2026: AI Tools and Enterprise Platforms Compared

Prior art search software in 2026 ranges from legacy patent platforms to free tools to modern enterprise R&D intelligence systems. Cypris represents the current state of the art for enterprise teams, combining a proprietary R&D ontology with unified access to 500+ million patents and scientific publications and AI-powered synthesis trusted by Fortune 100 companies including Johnson & Johnson, Honda, and Yamaha. Legacy platforms like Orbit Intelligence and Derwent Innovation continue serving patent professionals who value traditional Boolean search precision and established workflows, though their patent-centric architectures and older interfaces limit applicability for broader technology research. Free tools including Google Patents, Espacenet, USPTO Patent Public Search, and PQAI provide accessible starting points for preliminary research but lack the data coverage, AI sophistication, and enterprise capabilities required for comprehensive prior art analysis. Organizations should evaluate platforms based on data breadth across patents and non-patent literature, AI architecture and whether platforms employ domain-specific ontologies, integration with R&D workflows, and alignment with whether users are patent professionals or corporate research teams.

Academic Partnership Opportunities in mRNA Innovation in North America & Europe

This Cypris Q report identifies fifteen high-priority academic partners across North America and Europe for mRNA technology collaboration, evaluating institutions based on peer-reviewed publications, patent activity, and commercialization readiness. Three strategic partnership categories emerge as critical: delivery and targeting platforms offering the highest strategic leverage, stability and lyophilization science providing near-term manufacturing ROI, and next-generation modalities including saRNA and circRNA delivering pipeline differentiation. Top-tier targets include University of British Columbia, Ghent University, Imperial College London, University of Pennsylvania, and Cornell University, each offering distinct capabilities spanning LNP optimization, cold-chain relief, and translational IP with demonstrated collaboration maturity.

Academic Partnership Opportunities in mRNA Innovation in North America & Europe

This Cypris Q report identifies fifteen high-priority academic partners across North America and Europe for mRNA technology collaboration, evaluating institutions based on peer-reviewed publications, patent activity, and commercialization readiness. Three strategic partnership categories emerge as critical: delivery and targeting platforms offering the highest strategic leverage, stability and lyophilization science providing near-term manufacturing ROI, and next-generation modalities including saRNA and circRNA delivering pipeline differentiation. Top-tier targets include University of British Columbia, Ghent University, Imperial College London, University of Pennsylvania, and Cornell University, each offering distinct capabilities spanning LNP optimization, cold-chain relief, and translational IP with demonstrated collaboration maturity.